Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
10 years of interferon beta-1b (Beta feron therapy.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis Society Education Conference
Episode 28 with Dr. Brenda Banwell on pediatric MS
Characterization and quantitation of aggregates and particles in interferon-β products: Potential links between product quality attributes and immunogenicity.
Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.
Multiple Sclerosis: An Update.
Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
[The overall assessment of the quality of the physical health of patients with multiple sclerosis after the application of physical therapy. Part 1].
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Episode 21 with Dr. Paul Matthews discussing imaging in MS
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
Intrathecal interferon reduces exacerbations of multiple sclerosis.
Factors in Patient Empowerment: A Survey of an Online Patient Research Network.
Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
CinnoVex home page

Pages